doi: 10.1017/S0007114515005061 536 KimHYKimOHSungMK
Night-to-night variability of polysomnography-derived physiologic endotypic traits in patients with moderate to severe OSA
Large observational studies have confirmed this finding, with semaglutide showing the strongest effect
Same-day surgery workflows may identify GLP-1 use too late for ideal planning
Tuesdays announcement by the Institute for Clinical and Economic Review (ICER) that weight-loss drugs from Novo Nordisk and Eli Lilly are now cost-effective is an important victory for the two pharmaceutical companies, being that the assessment could pave the way for growth in US companies health insurance plans for their employees, according to a statement from Bank of America, whose analyst Tim Anderson follows Novo Nordisks US competitor, Eli Lilly.
Join others in Winthrop, Maine making informed decisions about their health through Klinic's expert support in managing your type 2 diabetes or weight loss needs with Mounjaro or alternative therapies